Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
On February 5th at 1:00 pm, join Neeraj Salathia, Director of Advanced Genomics, for a presentation on Rapid Multi-Omics Cell Therapy...
On January 22nd at 4:00 pm, join Mazen Karaman, Director of Platform Management – Cell Therapy, for a presentation on Expedited Cell Therapy QC.
Are you an innovative company seeking a reliable CDMO partner to help move your drug substance program to its next phase of success? Look no further.
With a discussion on cell line productivity and evolution, an exploration of the benefits of utilizing molecule optimization and engineering, and an...